Riikka Lund profile picture
Riikka
Lund
Senior Researcher, Finnish Functional Genomics Centre
Adjunct Professor, Institute of Biomedicine
Head of Finnish Functional Genomics Centre, group leader

Contact

+358 29 450 3793
+358 50 310 0060
Tykistökatu 6
20520
Turku

Areas of expertise

Epigenomics
genomics
transcriptomics
pluripotent stem cells
biomedicine
development
aging
molecular mechanisms of diseases
next-generation sequencing
genome-wide methods

Biography

Riikka Lund is the head of Finnish Functional Genomics Centre (2013-), a functional genomics core facility operating in Turku, Finland. In addition, she leads the Biomedical Epigenomics research group and is actively engaged in teaching. She is also a co-PI in the Biocenter Finland Genome-wide methods platform (https://www.biocenter.fi/index.php/technology-platform-services/genome-wide-methods), and since 2016, has been a co-director of the Computational and Molecular Methodologies for Life Sciences (CompLifeSci) Biocity Turku Research Programme (https://www.biocity.turku.fi/research-programmes/computational-and-molecular-methodologies-for-life-sciences-complifesci/). Since 2018 she has also been an editorial board member of Scientific Reports journal and provides expertise in many international tasks.

She completed her M.Sc. degree in 2001 with a major in genetics at the Department of Biology, Faculty of Mathematics and Natural Sciences, University of Turku, Finland. She carried out part of her studies at the Royal Melbourne institute of Technology, Australia. She gained her PhD in 2004 in Molecular Immunology and Medical Genetics at the Faculty of Medicine, University of Turku. She did her postdoc at the Centre for Stem Cell Biology, University of Sheffield in 2007-2008 with the focus on understanding genomic stability of pluripotent stem cells. In addition, to develop her expertise and update her skills in the latest technologies and research methods, she has carried out several short visits to national and international units (e.g. 2018 University of Southern Denmark; 2013 Broad Institute, USA; 2011 Diagenode, Belgium; 2009, 2006 University of Sheffied, UK; 2005 University of California, USA; 2002 Affymetrix, USA; 2001 Deutches Rheuma-Forschungszentrum, Germany). In 2013 she was awarded with the Millenium Distinct Technology Award for her contributions in stem cell research. In 2014 become Adjunct Professor in Molecular Biology in the faculty of Medicine, University of Turku.  

Teaching

Epigenomics; genomics; transcriptomics; next-generation sequencing; stem cells and regenerative medicine. 

Research

Biomedical Epigenomics group run by Lund exploits the latest technologies and cutting-edge methods to study genome function during early human development, aging and in diseases. The aim of the research is to understand how genetic and environmental factors influence development and health status of an individual and to reveal the molecular mechanisms of disease development. Furthermore, the goal is to find novel type of disease marker candidates and targets for drug development. By providing novel innovative approaches enabling prediction, early diagnosis and efficient precision treatment of diseases the ultimate goal of this research is to promote lifelong health.

Publications

Sort by:

Early Detection of Peripheral Blood Cell Signature in Children Developing Beta-Cell Autoimmunity at a Young Age (2019)

Diabetes
Henna Kallionpää, Juhi Somani, Soile Tuomela, Ubaid Ullah, Rafael de Albuquerque, Tapio Lönnberg, Elina Komsi, Heli Siljander, Jarno Honkanen, Taina Härkönen, Aleksandr Peet, Vallo Tillmann, Vikash Chandra, Mahesh Kumar Anagandula, Gun Frisk, Timo Otonkoski, Omid Rasool, Riikka Lund, Harri Lähdesmäki, Mikael Knip, Riitta Lahesmaa
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)